Simplification and Optimization of Transcatheter Aortic Valve Implantation - Fast-track Course Without Compromising Safety and Efficacy

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2018 Dec 12

PMID 30526521

Citations 7

Authors

Manik Chopra

Ngai H V Luk

Ole De Backer

Lars Sondergaard

Affiliations

Soon will be listed here.

Abstract

Transcatheter aortic valve implantation (TAVI) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis. Ageing of the Western and Asian population and expansion of indications for TAVI will lead to a substantial increase in the number of TAVI procedures performed worldwide within the next decades. In line with the maturation of TAVI over the past few years, there has also been a significant simplification and optimisation of the TAVI procedure. A minimalist TAVI procedure and fast-track TAVI course have been shown to have distinct advantages over the more traditional TAVI approach. The aim of this manuscript is to discuss strategies of TAVI simplification and optimization, with special focus on fast-track TAVI, without compromising safety and efficacy.

Citing Articles

Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation.

Stachel G, Jentzsch M, Oehring M, Antoniadis M, Schwind S, Noack T Int J Cardiol Heart Vasc. 2024; 51:101383.

PMID: 38496258 PMC: 10940133. DOI: 10.1016/j.ijcha.2024.101383.

Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic.

Wundram S, Seoudy H, Dummler J, Ritter L, Frank J, Puehler T BMC Cardiovasc Disord. 2023; 23(1):295.

PMID: 37301870 PMC: 10257817. DOI: 10.1186/s12872-023-03317-5.

Simplified TAVR Procedure: How Far Is It Possible to Go?.

Leclercq F, Meunier P, Gandet T, Macia J, Delseny D, Gaudard P J Clin Med. 2022; 11(10).

PMID: 35628919 PMC: 9145302. DOI: 10.3390/jcm11102793.

Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources?.

Kratochvilova L, Masek P, Neuberg M, Novackova M, Tousek P, Sulzenko J Eur Heart J Suppl. 2022; 24(Suppl B):B28-B35.

PMID: 35370505 PMC: 8971733. DOI: 10.1093/eurheartjsupp/suac009.

The COORDINATE Pilot Study: Impact of a Transcatheter Aortic Valve Coordinator Program on Hospital and Patient Outcomes.

Bohmann K, Burgdorf C, Zeus T, Joner M, Alvarez H, Berning K J Clin Med. 2022; 11(5).

PMID: 35268296 PMC: 8910867. DOI: 10.3390/jcm11051205.

References

Gurevich S, Oestreich B, Kelly R, Mbai M, Bertog S, Ringsred K . Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2017; 19(2):192-195. DOI: 10.1016/j.carrev.2017.08.002. View

Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra S, Mavromatis K . Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014; 7(8):898-904. DOI: 10.1016/j.jcin.2014.04.005. View

Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-98. DOI: 10.1056/NEJMoa1103510. View

Cilingiroglu M, Marmagkiolis K . A glimpse into the future of TAVR. Catheter Cardiovasc Interv. 2016; 87(1):152-3. DOI: 10.1002/ccd.26367. View

Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, Wintzer-Wehekind J . Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures. Catheter Cardiovasc Interv. 2016; 88(6):988-993. DOI: 10.1002/ccd.26666. View

Barbanti M, Binder R, Freeman M, Wood D, Leipsic J, Cheung A . Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013; 9(8):929-35. DOI: 10.4244/EIJV9I8A156. View

Jorgensen T, De Backer O, Gerds T, Bieliauskas G, Svendsen J, Sondergaard L . Immediate Post-Procedural 12-Lead Electrocardiography as Predictor of Late Conduction Defects After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018; 11(15):1509-1518. DOI: 10.1016/j.jcin.2018.04.011. View

Jabbar A, Khurana A, Mohammed A, Das R, Zaman A, Edwards R . Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement. Am J Cardiol. 2016; 118(11):1712-1716. DOI: 10.1016/j.amjcard.2016.08.051. View

Siontis G, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G . Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016; 37(47):3503-3512. DOI: 10.1093/eurheartj/ehw225. View

10.

Kornbau C, Lee K, Hughes G, Firstenberg M . Central line complications. Int J Crit Illn Inj Sci. 2015; 5(3):170-8. PMC: 4613416. DOI: 10.4103/2229-5151.164940. View

11.

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F . Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106(24):3006-8. DOI: 10.1161/01.cir.0000047200.36165.b8. View

12.

Barbash I, Barbanti M, Webb J, Molina-Martin de Nicolas J, Abramowitz Y, Latib A . Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015; 36(47):3370-9. DOI: 10.1093/eurheartj/ehv417. View

13.

Sud M, Qui F, Austin P, Ko D, Wood D, Czarnecki A . Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk. J Am Heart Assoc. 2017; 6(4). PMC: 5533033. DOI: 10.1161/JAHA.116.005460. View

14.

Barbanti M, Capranzano P, Ohno Y, Attizzani G, Gulino S, Imme S . Early discharge after transfemoral transcatheter aortic valve implantation. Heart. 2015; 101(18):1485-90. DOI: 10.1136/heartjnl-2014-307351. View

15.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Fleisher L . 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70(2):252-289. DOI: 10.1016/j.jacc.2017.03.011. View

16.

Coylewright M, Mack M, Holmes Jr D, OGara P . A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. J Am Coll Cardiol. 2015; 65(14):1472-80. DOI: 10.1016/j.jacc.2015.02.033. View

17.

Zhao A, Minhui H, Li X, Zhiyun X . A meta-analysis of transfemoral versus transapical transcatheter aortic valve implantation on 30-day and 1-year outcomes. Heart Surg Forum. 2015; 18(4):E161-6. DOI: 10.1532/hsf.1388. View

18.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

19.

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

20.

Barbanti M, Tamburino C . Optimisation of TAVI: is it mature enough to be defined as a PCI-like procedure?. EuroIntervention. 2015; 11 Suppl W:W110-3. DOI: 10.4244/EIJV11SWA32. View